65 citations,
January 2012 in “International Journal of Trichology” Trichotillomania, a condition where individuals compulsively pull out their own hair, often has a chronic course and is difficult to treat effectively. Traditional treatments have not been satisfactory for many patients. Recently, N-acetylcysteine, a glutamate modulator, has shown promise in treating trichotillomania and other compulsive behaviors. The document described two patients who were successfully treated with N-acetylcysteine, suggesting it as a new alternative for managing this condition. However, further studies were needed to determine the optimal treatment regimen and assess its long-term efficacy.
3 citations,
May 2018 in “Psychiatry and Clinical Psychopharmacology” Trichotillomania (TTM) is a challenging disorder to treat, often managed with selective serotonin reuptake inhibitors (SSRIs), though their effectiveness is uncertain. This document reported on an 18-year-old female patient with TTM who was successfully treated with the glutamate modulator n-acetylcysteine, highlighting a potential alternative treatment approach.
5 citations,
November 2011 in “Expert Review of Dermatology” The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.
14 citations,
February 2017 in “Anais brasileiros de dermatologia/Anais Brasileiros de Dermatologia” Trichotillomania is often misdiagnosed as alopecia areata and can be treated effectively with N-acetylcysteine and psychotropic drugs.
47 citations,
October 2014 in “Expert Opinion on Emerging Drugs” New alopecia treatments aim for better results and fewer side effects.